FindTrial
Sign In

Homoeopathic management of Lower urinary tract infection in a women between 18-60 years

A comparative study of cantharis vs. individualized homoeopathic medicine in women between 18-60 years in cases of lower urinary tract infection(LUTI) using UTI-SIQ-8 scale - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101860
Enrollment
60
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Cantharis vesicatoria: Catharis vesicatoria 30C will be administered orally 4 globules twice/day for 8 weeks. Intervention2: Individualized homoopathic medicine: Selection of homoeopath
Each dose 4 globules twice/day will be directed to be taken orally on clean tongue with empty stomach for 8 weeks.

Sponsors

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Only female patients aged between 18-60 years 2. Clinically diagnosed cases of lower urinary tract infection(LUTI), confirmed by relavent symptoms (e.g., burning urination, increased frequency, urgency, suprapubic pain duration less then 2 weeks) and supported by positive urine analysis (microscopic examination will identify WBC, with more then 10 WBC/ mL being suggestive of a UTI) 3. Participants who are willing to give informed consent and comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1. Patients with complicated UTI: Presence of upper UTI symptoms such as flank pain, fever more than 38 degree C, nausea/vomiting, or known upper UTI cases. 2. Pregnant and lactating women 3. Women with recurrent UTI history (more then 3 episodes in last 12 months) 4. Patients with chronic systemic disease such as DM, renal failure, or immunocompromised conditions (HIV/AIDS, canver hndergoing treatment)

Design outcomes

Primary

MeasureTime frame
Change in the severity of lower urinary tract infection(LUTI) symptoms as measured by the UTI-SIQ-8 (Urinary tract infection symptom impact questionnaire-8 ) score. reduction in UTI-SIQ-8 score from baseline to post trfeatment indication improvement in LUTI symptoms.Timepoint: Baseline (before initiation of treatment), at 4 weeks, and at 8 weeks (end of treatment period).—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Nidhi Jitendrakumar Pandya

Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University

partha.mandal27317@paruluniversity.ac.in9827261040

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026